1 Min Read
* Cytosorbents continues strong trajectory of growth in the third quarter 2017
* Total Q3 2017 revenues increased 59% to $3.8 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.